Evidence map›Paper›PMID 33954181›Full record

SynthesisBioMed research international2021

Efficacy and Safety of Qingpeng Ointment for Subacute and Chronic Eczema: A Systematic Review and Meta-Analysis.

Yan Li, Ming Li, Boyang Zhou, Zhou Liu, Linfeng Li

Open access · hybridAbstract readMeta-AnalysisSystematic Review
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in BioMed research international, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 95% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Yan LiDepartment of Dermatology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.ORCID https://orcid.org/0000-0001-6699-6304
Ming LiDepartment of Dermatology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.ORCID https://orcid.org/0000-0003-3489-5650
Boyang ZhouDepartment of Dermatology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.ORCID https://orcid.org/0000-0002-7962-3897
Zhou LiuDepartment of Dermatology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.ORCID https://orcid.org/0000-0002-8922-2552
Linfeng LiDepartment of Dermatology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.ORCID https://orcid.org/0000-0002-8736-6464
Capital Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo evaluate the efficacy and safety of Qingpeng ointment for the treatment of subacute and chronic eczema.

methodRandomized controlled trials (RCTs) on Qingpeng ointment for subacute and chronic eczema were searched on PubMed, the Cochrane Library, Embase, Web of Science, China National Knowledge Infrastructure, Wanfang Database, Chinese Biomedical Literature Database, and Chinese Science and Technology Periodical Journal from their inception to 30 November 2020. Quality assessment and data analysis were performed by Review Manager 5.3.

resultsA total of 26 RCTs were included. Qingpeng ointment could significantly improve the total efficacy rate (TER) (RR = 2.60, 95% CI: 2.11 to 3.21,

conclusionQingpeng ointment is an effective and safe treatment for subacute and chronic eczema. It is also an add-on treatment to TCS for eczema. However, due to the suboptimal quality of the included studies, more large-sample and high-quality RCTs are needed to improve the evidence quality.

Indexed as

Drugs, Chinese HerbalAdolescentAdultAgedAged, 80 and overChildChild, PreschoolChronic DiseaseEczemaHumansMiddle AgedOintmentsRandomized Controlled Trials as TopicTreatment OutcomeYoung AdultDrugs, Chinese HerbalOintments

Identifiers

PMID33954181
PMCPMC8064792
OpenAlexW3153680487

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.